Zimbabwe Signs MoU With Swiss Pharmaceutical Giant

ZIMBABWE signed a memorandum of understanding with a Swiss headquartered pharmaceutical company Novartis for patients to access medicines for non-communicable diseases at nominal prices.

By Kudakwashe Pembere

The signing ceremony done last week will see Zimbabwe each person get medicines for NCDs such as hypertension, diabetes and breast cancer for a dollar a month from Novartis’s unit, Sandoz DD.

Speaking after the announcement of the MoU, Dr Moyo expressed confidence that the collaboration would help provide improved health care and reduce preventable deaths.

“The issue of access to medicines is a critical issue for African countries and for Zimbabwe which has been grappling with shortages and high costs of medicines’, said Dr Moyo

On hand to welcome the Zimbabwe delegation were Novartis Head of Global Health and Corporate Responsibility Dr Patrice Matchaba and company Executives.

Explaining the rationale behind his company’s decision to partner with the Government of Zimbabwe, Group Head of Global Health & Corporate Responsibility for Novartis, Dr Patrice Matchaba is optimistic the deal will move forward.
“I am happy and would like this partnership to move forward in way to offer medicines and improve care to patients in Zimbabwe,” Dr Matschaba said.

During the visit in Basel the Minister and his delegation toured Novartis Continuous manufacturing drug development site which is a compact and more agile model and a major departure from the old models. The new plant has a very high output and has some elements that can be replicated in Zimbabwe.

Pharmaceuticals Group Novartis, is one of the world’s largest pharmaceutical companies Novartis in terms of global pharmaceutical sales.

During the visit in Basel the Minister and his delegation toured Novartis Continuous manufacturing drug development site which is a compact and more agile model and a major departure from the old models. The new plant has a very high output and has some elements that can be replicated in Zimbabwe.

The Minister was accompanied by Ambassador Mr Taonga Mushayavanhu and Permanent Representative of the Republic of Zimbabwe to the United Nations Office and other International Organisations in Geneva , Dr. Agnes Mahomva the Permanent Secretary and Dr. Gibson Mhlanga, Chief Director Preventive Services.
Novartis is a global company with a strong commitment to its Swiss roots. These stretch back over 150 years. The Novartis Campus in Basel is a place of knowledge, innovation and encounter. More than 2,500 scientists and over 7,500 employees from more than 100 countries are working here on the vision of a long and healthy life

 

Comments

comments

Share

Comments

comments

Related posts

Leave a Comment